Cargando…
A systematic review and critical assessment of incentive strategies for discovery and development of novel antibiotics
Despite the growing threat of antimicrobial resistance, pharmaceutical and biotechnology firms are reluctant to develop novel antibiotics because of a host of market failures. This problem is complicated by public health goals that demand antibiotic conservation and equitable patient access. Thus, a...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4775540/ https://www.ncbi.nlm.nih.gov/pubmed/26464014 http://dx.doi.org/10.1038/ja.2015.98 |